(2) Upon identifying a patient who exhibits or for whom the behavior outlined in subsection (1) has been exhibited, the Program Manager may provide relevant information to the identified health care practitioners who have prescribed or dispensed controlled substances to the identified patient within the 90-day period.
see full law